BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36252396)

  • 1. Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment.
    Huang X; Chen Y; Zhong W; Liu Z; Zhang H; Zhang B; Wang H
    Eur J Med Chem; 2022 Dec; 244():114817. PubMed ID: 36252396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-functional antitumor conjugates improving the anti-metastasis effect of combretastatin A4 by targeting tubulin polymerization and matrix metalloproteinases.
    Yang L; Ma X; Guo K; Li J; Zhang C; Wu L
    Eur J Med Chem; 2022 Aug; 238():114439. PubMed ID: 35551039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Dual Tubulin and Neuropilin-1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation.
    Zheng L; Zou Y; Xie T; Wu X; Tan Y; Mei S; Geng Y; Chen S; Xu S; Niu MM
    J Med Chem; 2023 Dec; 66(23):16187-16200. PubMed ID: 38093696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
    Kamal A; Shaik B; Nayak VL; Nagaraju B; Kapure JS; Shaheer Malik M; Shaik TB; Prasad B
    Bioorg Med Chem; 2014 Oct; 22(19):5155-67. PubMed ID: 25192811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
    Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
    Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel combretastatin A-4 derivative XN0502 induces cell cycle arrest and apoptosis in A549 cells.
    Zhu H; Zhang J; Xue N; Hu Y; Yang B; He Q
    Invest New Drugs; 2010 Aug; 28(4):493-501. PubMed ID: 20352291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers.
    Liu Z; Huang L; Zhou T; Chang X; Yang Y; Shi Y; Hao M; Li Z; Wu Y; Guan Q; Zhang W; Zuo D
    J Biol Chem; 2022 Jul; 298(7):102063. PubMed ID: 35618020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Combretastatin-A4 Carboxamidest that Mimic Sulfonyl Piperazines by a Molecular Hybridization Approach: in vitro Cytotoxicity Evaluation and Inhibition of Tubulin Polymerization.
    Jadala C; Sathish M; Anchi P; Tokala R; Lakshmi UJ; Reddy VG; Shankaraiah N; Godugu C; Kamal A
    ChemMedChem; 2019 Dec; 14(24):2052-2060. PubMed ID: 31674147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase.
    Hua S; Chen F; Wang X; Gou S
    Eur J Med Chem; 2020 Mar; 189():112041. PubMed ID: 31954880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and biological evaluation of dual tubulin/HDAC inhibitors based on millepachine for treatment of prostate cancer.
    Xie S; Leng J; Zhao S; Zhu L; Zhang M; Ning M; Zhao B; Kong L; Yin Y
    Eur J Med Chem; 2024 Mar; 268():116301. PubMed ID: 38452727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazopyridine linked triazoles as tubulin inhibitors, effectively triggering apoptosis in lung cancer cell line.
    Sayeed IB; Vishnuvardhan MVPS; Nagarajan A; Kantevari S; Kamal A
    Bioorg Chem; 2018 Oct; 80():714-720. PubMed ID: 30075408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 6-p-tolyl-3-(3,4,5-trimethoxybenzyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivative as a potent tubulin inhibitor with promising in vivo antitumor activity.
    Ji T; Jian X; Chen L; Zeng W; Huo X; Li M; Chen P; Zhang Y; You W; Zhao P
    Eur J Med Chem; 2023 Aug; 256():115437. PubMed ID: 37172475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of (2-(pyrrolidin-1-yl)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone as a novel potent tubulin depolymerizing and vascular disrupting agent.
    Tian C; Wang M; Shi X; Chen X; Wang X; Zhang Z; Liu J
    Eur J Med Chem; 2022 Aug; 238():114466. PubMed ID: 35635956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.
    Wang Y; Sun M; Wang Y; Qin J; Zhang Y; Pang Y; Yao Y; Yang H; Duan Y
    Eur J Med Chem; 2021 Dec; 225():113790. PubMed ID: 34454126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel 1-indolyl acetate-5-nitroimidazole derivatives of combretastatin A-4 as potential tubulin polymerization inhibitors.
    Yao YF; Wang ZC; Wu SY; Li QF; Yu C; Liang XY; Lv PC; Duan YT; Zhu HL
    Biochem Pharmacol; 2017 Aug; 137():10-28. PubMed ID: 28456516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study.
    Ma W; Chen P; Huo X; Ma Y; Li Y; Diao P; Yang F; Zheng S; Hu M; You W; Zhao P
    Eur J Med Chem; 2020 Dec; 208():112847. PubMed ID: 33022479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
    Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.